PHILADELPHIA CHROMOSOME POSITIVE CML
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE CML explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE CML trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Drug attack on blood cancer aims to free patients from daily pills
Disease control OngoingThis study is testing if starting with a stronger drug (ponatinib) for 6 months, then switching to a standard drug (imatinib), can help people with a type of blood cancer called CML. The goal is to get the cancer under such good control that some patients might eventually be able…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for kids with rare blood cancer
Disease control OngoingThis study is testing a drug called bosutinib for children with a specific type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (CML). It aims to find the right dose for kids and see how safe and effective it is, both for newly diagnosed patients and …
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC